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Abstract The molecular mechanisms underlying sponta-
neous neoplastic transformation in cultured mammalian
cells remain poorly understood, confounding recognition
of parallels with the biology of naturally occurring cancer.
The broad use of tumorigenic canine cell lines as research
tools, coupled with the accumulation of cytogenomic data
from naturally occurring canine cancers, makes the domes-
tic dog an ideal system in which to investigate these
relationships. We developed a canine kidney cell line,
CKB1-3T7, which allows prospective examination of the
onset of spontaneous immortalization and tumorigenicity.
We documented the accumulation of cytogenomic aberra-
tions in CKB1-3T7 over 24 months in continuous culture.
The majority of aberrations emerged in parallel with key
phenotypic changes in cell morphology, growth kinetics,
and tumor incidence and latency. Focal deletion of
CDKN2A/B emerged first, preceding the onset and pro-
gression of tumorigenic potential, and progressed to a
homozygous deletion across the cell population during
extended culture. Interestingly, CKB1-3T7 demonstrated
a tumorigenic phenotype in vivo prior to exhibiting loss of
contact inhibition in vitro. We also performed the first
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genome-wide characterization of the canine tumorigenic
cell line MDCK, which also exhibited CDKN2A/B dele-
tion. MDCK and CKB1-3T7 cells shared several addition-
al aberrations that we have reported previously as being
highly recurrent in spontaneous canine cancers, many of
which, as with CDKN2A/B deletion, are evolutionarily
conserved in their human counterparts. The conservation
of these molecular events across multiple species, in vitro
and in vivo, despite their contrasting karyotypic architec-
ture, is a powerful indicator of a common mechanism
underlying emerging neoplastic activity. Through integrat-
ed cytogenomic and phenotypic characterization of serial
passages of CKB1-3T7 from initiation to development of a
tumorigenic phenotype, we present a robust and readily
accessible model (to be made available through the
American Type Culture Collection) of spontaneous neo-
plastic transformation that overcomes many of the limita-
tions of earlier studies.
Keywords Neoplastic transformation . Tumorigenicity .
Canine chromosomes . Comparative genomic
hybridization (CGH) . Fluorescence in situ hybridization
(FISH) .Madin-Darby canine kidney (MDCK) cell line .
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Introduction
It has been evident since the 1940s that untreated mam-
malian cells propagated in culture can evolve during serial
passage to express a tumorigenic phenotype, defined as the
capacity to form tumors when inoculated into immuno-
compromised rodents (Gey 1941; Earle et al. 1943). Since
these early observations, several immortalized cell lines,
established from a variety of different species, have been
documented to develop the ability to form tumors in vivo,
spontaneously and without chemical or genetic modifica-
tion (Macpherson and Stoker 1962; Defendi et al. 1963;
Aaronson and Todaro 1968; Jarrett andMacpherson 1968;
Contreras et al. 1985; Kraemer et al. 1987; Rubin et al.
1990; United States of America Food and Drug
Administration 2005; Manohar et al. 2008; Liu et al.
2010; Onions et al. 2010; Omeir et al. 2011). Notable
among these are the Madin-Darby canine kidney
(MDCK) cell line (Madin and Darby 1958; United States
of America Food and Drug Administration 2005;
Gregersen 2008; Liu et al. 2010; Onions et al. 2010;
Omeir et al. 2011; Brinster et al. 2013) and the VERO line
ofAfrican greenmonkey kidney (AGMK) cells (Contreras
et al. 1985; Manohar et al. 2008). The MDCK and VERO
cell lines are used as substrates for viral vaccine production
(Barrett 1980; Montagnon 1989; Medema et al. 2006;
Betakova et al. 2013). The use of tumorigenic cell lines
in this context has raised concerns over the potential for
vaccine-mediated transfer of neoplastic activity by cellular
components, such as oncogenic viruses and cellular DNA
(Sheng-Fowler et al. 2009), and subcellular components
such as exosomes and microRNAs (Fevrier and Raposo
2004; Lujambio and Lowe 2012). A rigorous assessment
of these concerns requires a comprehensive understanding
of the complex processes that govern the acquisition of a
tumorigenic phenotype. Studies in vitro have revealed a
multistage series of cellular events evolving from genomic
and epigenetic alterations that provide growth advantages
to replicating cells (Barrett 1980; Thomassen 1986; Rubin
2005; Buonanno et al. 2011). These investigations have
focused heavily on individual loci of specific interest, and
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the few genome-wide reports have been limited in resolu-
tion, confounding the ability to correlate molecular alter-
ations with biological behavior. Furthermore, many prior
studies represent retrospective investigations of induced
rather than spontaneous transformation, often in rodent cell
line models, restricting opportunities for correlation of
in vitro observations with in vivo data from naturally
occurring tumors within the same species.
Our recent evaluation of the complex tumorigenic phe-
notype of MDCK cells (Omeir et al. 2011; Brinster et al.
2013) offers the potential for molecular characterization of
this widely used cell line in context with the expanding
catalog of genomic profiling data arising from naturally
occurring tumors of domestic dogs (Breen 2009; Thomas
et al. 2009, 2011, 2014; Angstadt et al. 2011; Hedan et al.
2011; Poorman et al. 2015; Shapiro et al. 2015).
Unfortunately, the biological characteristics of the
MDCK cell line following initiation of the original culture
are not well documented (Madin and Darby 1958; Gaush
et al. 1966; Leighton et al. 1969; Rindler et al. 1979; Saier
1981), and the event that resulted in transformation of
MDCK cells into a continuous cell line is not recorded.
Furthermore, several biologically heterogeneous deriva-
tives of the original line are in use today (Dukes et al.
2011). These limitations, coupled with the fact that early
nontumorigenic MDCK cell populations are no longer
available, preclude the ability to investigate the evolution
of this phenotype in a progressive manner.
We describe the development of a new canine kidney
cell line, CKB1-3T7, which permits a prospective inves-
tigation of emerging neoplastic events in vitro and over-
comes many of the limitations of earlier studies. We
present a comprehensive cellular and molecular charac-
terization of serial passages of the CKB1-3T7 cell line
banked at regular intervals over a 2-year period of con-
tinuous culture. These cell banks encompass the spec-
trum of events leading from cell line initiation to immor-
talization and the development and progression of tumor-
igenic activity. We compare these data with biological
and cytogenomic profiles we obtained from the MDCK
cell line to identify conserved features that support the
independent association of specific genomic alterations
with cellular phenotype. Finally, we discuss the degree to
which these observations recapitulate the profiles of
genomic instability evident in naturally occurring can-
cers. We propose that this series of well-characterized
reagents confers a robust and widely accessible system
for systematically elucidating the biological intricacies
of neoplastic development in mammals.
Materials and methods
Development of the CKB1-3T7 cell line
Healthy canine kidney tissue was provided by the
National Institutes of Health (NIH) Division of
Veterinary Services. Kidneys were obtained from a
healthy 2-year-old male Beagle (Charles River
Laboratories, Frederick, MD) used in an Institutional
Animal Care and Use Committee (IACUC)-approved
study of the effects of int ra-aor t ic balloon
counterpulsation on septic shock (Solomon et al.
2009). Histopathological evaluation of formalin-fixed
tissue sections from the specimen was unremarkable.
Representative fresh tissue was washed three times with
phosphate-buffered saline (PBS), minced into 2–3 mm
pieces, and disaggregated with 0.25 % trypsin
(Mediatech, Manassas, VA) for 1 h at 37 °C with shak-
ing. The disaggregated cells were washed three times
with PBS and resuspended in 15 mL Dulbecco’s mod-
ified Eagle’s medium (DMEM,Mediatech) supplement-
ed with 10 % fetal bovine serum (FBS, Lot ASL31024;
Hyclone, Logan, UT), 2 mM L-glutamine (Mediatech)
(DMEM-10), and antibiotics [penicillin 100 U/mL,
streptomycin 100 μg/mL, gentamicin 50 μg/mL
(Mediatech), and 10 μg/mL tetracycline (Webster
Veterinary Supply, Devens, MA)]. Cells were plated
into two T75 flasks (Corning Incorporated, Corning,
NY) and incubated at 37 °C, 5 % CO2. Beginning at
passage (p) 3, cells were cultured in DMEM-10 without
antibiotics. Upon reaching confluence, approximately
4×105 cells/mL were cryopreserved by resuspension
in 1 mL of 7.5 % dimethylsulfoxide (DMSO, Sigma
Aldrich, St. Louis, MO) in DMEM-10 and stored in the
vapor phase of liquid nitrogen. For cell line establish-
ment, p3 cells (approximately 4×105 cells) were
thawed, plated in a T25 flask (Corning) in DMEM-10,
and incubated at 37 °C, 5 % CO2. The medium was
replaced every 3–4 days for 6 weeks by which time the
cells were confluent. By p9, cell growth was such that
cells plated at 3×105 cells/T25 flask were consistently
95–98 % confluent after 7 days in culture, making it
possible to initiate serial passaging.
For serial passage (p10–p90), at 7-day intervals, cells
from two T25 flasks were washed with PBS-EDTA
(Teknova, Hollister, CA), detached by incubation in
0.25 % trypsin (Mediatech) and 0.53 mM EDTA
(Quality Biological Inc., Gaithersburg, MD), and
pooled. The number of cells was determined using a
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Cellometer (Nexcelom Bioscience, Lawrence, MA),
and the cell suspension was used to seed T25 flasks
with 3×105 cells (1.2×104 cells/cm2) in DMEM-10 for
the next passage. During serial passage, cell mono-
layers, cell morphology, and cell-sheet confluence were
monitored daily. Based on the origin of the tissue and
the method of culture (Todaro and Green 1963), the cell
line was designated CKB1-3T7: canine kidney Beagle1
[CKB1]—3×105 cells, transferred [T] every 7days. The
same lot of FBS was used throughout the establishment
and propagation of CKB1-3T7 cells. The cell line tested
negative for 31 rodent agents (26 viruses and mycoplas-
ma species/pulmonis; IDEXXRADIL, Columbia, MO).
Cells banked every ten passages from p10 to p90 will be
available from the American Type Culture Collection
(ATCC, Manassas, VA).
Cell growth characteristics
The doubling time (DT) of CKB1-3T7 cells in hours
was determined at each passage. Every 7 days, cells
from two of the T25 flasks plated at 3×105 cells/flask
for passage were harvested. The number of cells plated
at passage initiation and the number of cells after 7 days
(168 h) in culture were used to determine the doubling
time using the formula: 1/[((log B−log A)×3.32)/168],
where A = initial number of cells plated, B = final
number of cells in the flask, and 3.32 represents
1/log2. Population doubling levels (PDL) were deter-
mined by the formula: PDL=PDLi+3.32×(total viable
cells at harvest/total viable cells at plating), where PDLi
= the PDL of the previous passage.
To evaluate the cell growth characteristics at ten-
passage intervals, a 95–98 % confluent monolayer of
CKB1-3T7 cells from a T150 flask seeded at 1.2×104
cells/cm2 was split into 30 T25 flasks at 3×105 cells/
flask and the medium replaced every 3–4 days for
20 days (480 h) to 28 days (672 h). Every 2–3 days,
cells in two T25 flasks were trypsinized and pooled, and
the average number of cells/flask was determined.
Assays were performed in duplicate, and the values for
the average numbers of cells were used to graph popu-
lation growth over time.
Cell migration and tumorigenicity assays
Wound-healing assays were undertaken to evaluate
potential changes in the migration phenotype of
CKB1-3T7 cells at different passage levels. Onemillion
cells were plated in triplicate in 60-mm-diameter culture
dishes.When cultures reached 90% confluence, cells were
serum starved for 8 h, and the monolayers were wounded
with a P200 pipette tip, washed with PBS, and cultured in
DMEM-10. Phase-contrast images of cell migration into
thewounded areawere photographed at 0, 12, 24, and 36 h
using an Olympus IX51 microscope with a DP72 camera
and a ×20 objective. Cell migration (% of wound closure)
was determined at 36 h by the formula [(initial wound size
−wound size at time of measurement)/initial wound
size]×100.
Tumorigenicity studies were performed as described
previously (Omeir et al. 2011) in both newborn and
adult mice due to the difference in sensitivity (newborn
mice being more sensitive) to tumor formation. Briefly,
newborn (<72 h old) and adult (4–6 weeks old) athymic
nude mice (Frederick Cancer Research Facility,
National Cancer Institute, NIH) were inoculated subcu-
taneously in the dorsal region of the thorax above the
scapulae with 107 cells in 0.1 mL PBS per mouse. The
animals were examined weekly for 12 months for the
presence and progression of tumors. Progressive tumor
growth was determined by two-dimensional measure-
ments at weekly intervals using a VWR Digital Caliper
(VWR International, Radnor, PA). Tumor incidence
data, represented by the percent of tumor-free animals,
were plotted as Kaplan-Meier survival curves. Mice
were euthanized when tumors reached approximately
20 mm in any dimension. All institutional and national
guidelines for the care and use of laboratory animals
were followed, and the protocols for these assays were
approved by the IACUC of the Center for Biologics
Evaluation and Research.
Preparation of selected cell line passages
for cytogenomic analysis
Cytogenomic analysis of CKB1-3T7 cells was per-
formed initially at p7, p15, and p22 and subsequently
at intervals of approximately ten passages (p32, p43,
p52, p62, p73, and p92), representing a period of con-
tinual propagation over 24 months. Duplicate flasks for
each selected passage were allowed to approach conflu-
ence, the cells were rinsed with Hanks’ balanced salt
solution (Mediatech), disaggregated with 0.05 %
trypsin/EDTA (Mediatech), pooled, and split equally
into three new T75 flasks in 25 mL of DMEM-10 per
flask. Cultures were propagated until approaching con-
fluence, at which time the cells from one flask were
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cryopreserved in 10 % DMSO/90 % FBS (Mediatech).
Cells from the two remaining flasks were arrested at
metaphase by exposure to 50 ng/mL Karyomax (Gibco/
Life Technologies, Grand Island, NY) for 16 h (flask 1)
and 100 ng/mL Karyomax for 4 h (flask 2). Cells from
both flasks were recovered by trypsin-EDTA treatment
and pooled. The combined cell number was determined
using a Cellometer and divided into two equivalent
aliquots. The first aliquot was harvested with conven-
tional hypotonic treatment and 3:1 methanol/glacial
acetic acid fixation. Metaphase chromosome prepara-
tions were dropped onto clean, uncharged glass micro-
scope slides; cured for 3–5 days at room temperature;
dehydrated through 70, 90, and 100 % ethanol baths;
and stored at −80 °C until required. The second aliquot
of cells was rinsed in PBS and used for isolation of total
genomic DNA (Qiagen DNeasy Blood and Tissue Kit,
Qiagen, Valencia, CA).
Genomic DNA copy number profiling analysis
of CKB1-3T7 cells
Oligonucleotide-array comparative genomic hybridization
(oaCGH) analysis was performed as described previously
(Poorman et al. 2015; Thomas et al. 2014; Shapiro et al.
2015), using a custom 1,000,000-feature microarray
(Agilent Technologies, Santa Clara, CA). The array com-
prises repeat-masked ∼60-mer oligonucleotides distributed
at approximately 2.4 kb intervals throughout the domestic
dog genome sequence assembly (Lindblad-Toh et al.
2005). The genome-wide DNA copy number profile of
each of the nine serial cell line passages (Btest^ samples)
was evaluated in a series of pairwise hybridizations against
a common reference sample comprising equimolar quan-
tities of blood-derived DNA acquired from five, young
(<3 years), clinically healthy, male Beagles during routine
wellness examinations. Array image data were processed
using Feature Extraction version 10.10 and Genomic
Workbench version 7 (Agilent Technologies). Raw data
were filtered to exclude probes exhibiting nonuniform
hybridization or signal saturation. Nonrandom, recurrent
DNA copy number aberrations (CNAs) were defined
using the ADM2 segmentation algorithm in Genomic
Workbench with a threshold of six, based on a minimum
of three consecutive probes with log2 test:reference values
≥0.2 (copy number gain) or ≤−0.2 (copy number loss),
resulting in an effective resolution of∼4.8 kb (two intervals
of ∼2.4 kb). High-amplitude gains and losses were defined
using default log2 test:reference values of >1.14 and <−1.1,
respectively. Genes and uncharacterized coding sequences
within recurrent CNAs were defined using the UCSC
canine genome sequence browser (http://genome.ucsc.
edu/). Discrete genomic regions are herein denoted
according to their cytogenetic location and their
megabase (Mb) coordinates within the dog genome se-
quence assembly (Lindblad-Toh et al. 2005). Dog chro-
mosome Y (Canis familiaris (CFA) Y) was excluded from
analysis due to the absence of this chromosome in the
female dog genome sequence assembly.
Targeted fluorescence in situ hybridization (FISH)
analysis of CKB1-3T7
KeyCNAs identified by oaCGH analysis were selected for
targeted FISH analysis based on their emergence and/or
change in amplitude during cell line propagation. FISH
analysis was performed using metaphase chromosome
preparations obtained from an aliquot of the same cell
population of each passage from which DNAwas extract-
ed for use in oaCGH. Two types of FISH probes were
used. Fluorescently labeled single-locus probes (SLPs)
were generated using cytogenetically validated bacterial
artificial chromosome (BAC) clones from the RPCI-81
or CHORI-82 canine BAC libraries (https://bacpac.chori.
org) (Thomas et al. 2007, 2008).Whole chromosome paint
probes were prepared from bivariate flow-sorted dog
chromosomes (Breen et al. 1999b). All FISH probes
were first hybridized to metaphase chromosome prepa-
rations from clinically healthy dogs to validate signal
quality and location (Breen et al. 1999b; Thomas et al.
2008). Pools of differentially labeled FISH probes were
then used to assess the range and distribution of both
structural and numerical chromosome aberrations in up
to 50 cells from each of the passages evaluated by
oaCGH analysis.
Cytogenomic evaluation of the MDCK cell line
Cells from three different lots of parental MDCK cells
(NBL-2, catalog number CCL-34) were obtained from
the ATCC. The biological characteristics of these cells
have been described previously (Omeir et al. 2011).
Briefly, MDCK vial 1 (V1: lot no. 3563161, frozen
January 30, 2004) was acquired at p55 and maintained in
DMEM-10. MDCK vial 2 (V2: lot no. 4398972, frozen
January 20, 2006) and vial 3 (V3: lot no. 7643577, frozen
July 20, 2007) were received at p56 and p55, respectively,
and were propagated using ATCC-formulated EMEM
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supplemented with 10 % FBS. V1 and V2 cells originated
from the same token lot established at p52. V3 cells were
established from a different token lot that was also
established at p52. These different MDCK cell lots exhibit
differing tumor-forming capacity in athymic nude mice,
with log10 tumor-producing doses at 50 % endpoints
[TPD50] of 5.2 (V1), 4.4 (V2), and 5.8 (V3) (Omeir et al.
2011). Cells from all three lots were evaluated by oaCGH
and FISH analyses as described above.
Results
Evolution of growth rate, morphology,
and tumorigenicity in CKB1-3T7 cells
During the first 30 passages after initiation, CKB1-
3T7 cells demonstrated a gradual increase in growth
rate, with the DT decreasing 1.8-fold from 107.5 h at
p14 to 60.3 h at p32 (Fig. 1a). During this period, the
cell population exhibited a mixture of cells with
epithelial and mesenchymal characteristics (SOM
Fig. 1A). By p42, the DT decreased further to
37.3 h (Fig. 1a), and the morphological composition
of the cell culture began to evolve, becoming pre-
dominantly cuboidal by p50 (SOM Fig. 1B). Both
cell morphology and the DT subsequently remained
stable for the next 20 passages (30.4 h at p62, 30.9 h at
p72, and 31.7 h at p82). Loss of contact inhibition emerged
by p90, with the cell sheets exhibiting multilayer areas
throughout the flask (SOMFig. 1C), resulting in a decrease
in DT, an increase in cell density, and a sustained popula-
tion expansion (Fig. 1a).
Wound-healing and tumor formation assays were
performed to assess the relationship between cell
migration and tumor-forming ability in CKB1-3T7
cells. At p32 and p42, there was little or no motility
observed during wound-healing assays at 36 h, but
there was a progressive increase in migratory capac-
ity from p52 (51.4 % wound closure) to p74
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NB p51    (1/6)
AD p50  (0/10)
NB p60    (0/8)
AD p60  (1/11)
NB p71  (6/12)
AD p72  (1/10)
NB p81 (11/16)
AD p81   (4/10)
NB p90 (13/15)
AD p90   (5/11)
a
b
Fig. 1 CKB1-3T7 cell growth
characteristics and
tumorigenicity. a Population
growth, cell doubling times (DT),
and population doubling levels
(PDL) of CKB1-3T7 cells
sampled at approximately ten
passage intervals from cell line
initiation. b Kaplan-Meier curves
of tumor formation in newborn
(NB) and adult (AD) athymic
nude mice after inoculation with
107 CKB1-3T7 cells. The graphs
plot the percent of mice that are
tumor-free over time, while the
numbers in parentheses indicate
the tumor incidence at end of the
experiment
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(71.4 % wound closure), with the wound being
100 % closed at p94 (SOM Fig. 2). From p50,
CKB1-3T7 cells showed a gradual onset of tumor-
forming capacity and a decrease in the interval be-
tween cellular inoculation and the appearance of a
tumor (tumor latency). The incidence of tumor for-
mation in newborn athymic nude mice increased
from 1/6 (83 % tumor-free) at p51 to 13/15 (13 %
tumor-free) at p90, with tumor latency falling from
26–28 weeks (p51) to 2–3 weeks (p90) (Fig. 1b). In
contrast, tumor formation in adult nude mice was
first observed at p60 (1/11, 91 % tumor-free), increas-
ing to 5/11 (55 % tumor-free) at p90, with a marked
decrease in tumor latency from 52–53 weeks (p60) to 2–
3 weeks (p90) (Fig. 1b). Two tumors that formed in
newborn athymic nude mice inoculated with p90 cells
regressed.
Evolution of genomic profiles during propagation
of CKB1-3T7 cells
Genome-wide DNA copy number profiling demonstrat-
ed that the evolution in cell growth, morphology, and
tumor-forming potential of CKB1-3T7 cells during
propagation from p7 to p92 was accompanied by a
progressive accumulation of DNA copy number aberra-
tions (Fig. 2 and SOM Fig. 3). Cells at p7 exhibited a
grossly balanced DNA copy number profile in oaCGH
analysis, and the number and morphology of chromo-
somes was consistent with that of the normal dog
karyotype [2n=78, (Breen et al. 1999a)]. Apparent
regional genomic imbalances at p7, including copy
number losses of CFA 9q14:20.7 Mb and CFA
19q13.1:14.4 Mb, coincided with natural DNA copy
number polymorphisms that have been described in
Fig. 2 Integrated summary of the evolution in cellular and
cytogenomic characteristics during long-term propagation of
CKB1-3T7 cells. CNAs identified by oaCGH analysis are shown
against the interval in which they emerged, denoted in blue (gain)
or red (loss). The change in breadth of the arrow denoting the
CDKN2A/B deletion reflects the progressive increase in the
amplitude of this CNA in the successive passages analyzed.
Overlaid on these data are key time points associated with
the biological phenotype of each passage
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the domestic dog (Chen et al. 2009; Nicholas et al.
2009) and remained evident in subsequent passages.
oaCGH analysis of cells at p15 detected deletions of
CFA 27 and CFA 36 and also a low amplitude focal
deletion of a 1.04 Mb interval on CFA 11q16:44.17–
45.20 Mb, a region containing the full length of the
MTAP, CDKN2A/B, and DMRTA1 loci. Targeted FISH
analysis demonstrated hemizygous interstitial deletion
of this interval on CFA 11q16 in 49 % of cells evaluated
at p15 (Figs. 3 and 4). The amplitude (log2 test:reference
ratio) of this deletion continued to increase progressive-
ly in p22 and p32 cells (Figs. 3 and 4), at which time
genomic profiles remained otherwise consistent with
that of cells at p15. At p32, FISH analysis demonstrated
hemizygous deletion of CFA 11q16:44.17–45.20 Mb in
50 % of cells, with the remainder of the population
exhibiting homozygous deletion. The amplitude of the
aberration began to plateau at p43, at which time this
region of CFA 11q16 was undetectable in 91.5 % of
cells by FISH analysis (Figs. 3 and 4). oaCGH analysis
of p43 cells also revealed that the copy number status of
CFA 27, which was reduced to n=1 in 24.1 % of cells at
p32, had returned to a balanced state. FISH analysis using
a chromosome paint probe representing CFA 27 showed
that this return to n=2 coincided with the appearance of
two derivative chromosomes, each formed by fusion of
one copy of CFA 27 with a second, unidentified chromo-
some (Fig. 4). These derivatives remained evident through-
out continued propagation of CKB1-3T7. oaCGH analysis
at p43 also revealed gain of CFA 13 and loss of CFA 16,
which FISH analysis showed to be consistent with trisomy
and monosomy, respectively (Fig. 4). No additional
changes were evident at p52. At p62, gain of CFA 1
became evident along with a low amplitude gain of
∼9.6 Mb at CFA 5q34-q35:76.21–85.77 Mb, followed at
p73 by gain of CFA 9 and an increase in the amplitude of
gain at CFA 5q34-q35. The discrete gain of CFA 5q34-
q35:76.21–85.77 Mb was evident in FISH analysis as a
tandem duplication in 23%of p73 cells evaluated (Fig. 4).
By p92, this aberrationwas detected in only 3.1% of cells,
consistent with return to a grossly balanced state indicated
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Fig. 3 Assessment of DNA copy
number status at the CDKN2A/B
locus on CFA 11q16 in CKB1-
3T7 cells. The mean copy number
of the region as determined by
FISH analysis of serial passages
of CKB1-3T7 cells is shown on
the primary vertical axis to the
left. The secondary vertical axis
on the right indicates the
corresponding test:reference
signal intensity value at this locus
as determined by oaCGH
analysis. These values are plotted
on a linear (rather than
logarithmic scale) to aid
comparison with FISH data for
the same passage
Fig. 4 Multicolor FISH analysis of CKB1-3T7 cells over succes-
sive passages. a FISH analysis with two five-color probe sets.
SLPs were targeted to detect the central region of the chromosome
or subchromosomal region of interest. Panel 1 (ai, bi, ci, and di)
comprises SLPs for regions of CFA 1:62 Mb (red), CFA 9:20 Mb
(magenta), CFA 9:33.5 Mb (gold), CFA 19:15 Mb (green), and
CFA 27:22Mb (aqua), and panel 2 (aii, bii, cii, and dii) comprises
SLPs for regions of CFA 5:83 Mb (red), CFA 11:43.8 Mb (green),
CFA 11[CDKN2A/B]:44.3 Mb (gold), CFA 13:28 Mb (magenta),
and CFA 16:33 Mb (aqua). The BAC clone representing CFA 13
also contains the full length of theMYC gene (Thomas et al. 2007,
2008). The numbers in parentheses adjacent to the probe in each
figure refer to the mean SLP copy number derived from counts of
up to 50 cells from clinically normal control dog chromosomes (ai,
aii) and from CKB1-3T7 cell line chromosomes at p43 (bi, bii),
p73 (ci, cii), and p92 (di, dii). Aqua arrowheads in bi, ci, and di
indicate use of a CFA 27 whole chromosome paint probe in place
of the SLP to permit structural as well as numerical analysis. Pink
and aqua asterisks in cii and dii indicate abnormal derivatives
containing at least a segment of CFA 13 (pink asterisk) and CFA
16 (aqua asterisk). BAC addresses for clones used to generate
each SLP are provided in SOM Table 1. Size bars represent 5 μm.
b Graphical representation of the mean copy number of each SLP
assessed across all CKB1-3T7 cell passages analyzed. The SLP at
CFA 11:44.3 Mb includes the CDKN2A/B locus
b
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accumulated gain of CFA 14 and 38 and deletion of the
central region of CFA 18 (CFA 18q12-q24:13.81–
43.74 Mb). The amplitude of the interstitial deletion of
CFA 11q16:44.17–45.20 Mb in oaCGH analysis
reached a maximum at p92, at which time this region
was rarely detectable in cells analyzed by FISH analysis
(Figs. 3 and 4). The genomic location of all FISH probes
is provided in SOM Table 1.
Genomic profiling analysis of MDCK cells
oaCGH analysis of MDCK V1, V2, and V3 cells dem-
onstrated relatively limited DNA copy number imbal-
ance (Fig. 5). This was supported by observations from
chromosome enumeration (V1 mean=77, range 76–79;
V2 and V3 mean=80, range 78–82 and 78–83, respec-
tively). Cells from all three lots showed elevated copy
number along the length of CFA X relative to the male
reference in oaCGH analysis (Fig. 5) and exhibited two
bi-armed (submetacentric) chromosomes, both of which
hybridized CFA X-specific FISH probes (Fig. 6). All
other chromosomes appeared to be acrocentric. No CFA
Y signal was detected in FISH analysis (Fig. 6), and
each cell lot tested negative for the CFAY-specific sex-
determining region (SRY) using PCR analysis
((Bannasch et al. 2005; data not shown). The natural
DNA copy number polymorphisms observed for CFA
9q14:20.7Mb and CFA 19q13.1:14.4Mb in CKB1-3T7
cells were also evident in cells from all three lots of
MDCK cells. All three showed targeted interstitial de-
letion of a 60-kb region at CFA 11q16:44.23–44.29 Mb,
consistent with homozygous loss ofCDKN2A/B and the
distal end (exons 7 and 8) of the MTAP gene, and also
shared gain along the length of CFA 14 and CFA 17. In
contrast to the CKB1-3T7 cell line, FISH analysis of this
region in MDCK cells showed a near-balanced copy
number status (n≥1.96) in all cells scored (Fig. 7).
This was consistent with the smaller interval of deletion
around the CDKN2A/B region in MDCK cells (60 kb)
versus CKB1-3T7 cells (1.04Mb), relative to the size of
the BAC clone used in FISH analysis of that region
(172 kb).
Other DNA copy number aberrations were evident in
oaCGH profiles of only one or two of the MDCK lots.
V2 and V3 cells shared common gains of CFA 8, CFA
13, and CFA 38. V3 cells showed gain of CFA 35,
which was also evident at low amplitude in V2 cells
but fell outside the threshold required for classification
as aberrant in oaCGH. V1 cells showed several aberra-
tions that were not evident in the other two cell lots,
including partial losses of CFA 4q33-qtel:73.67–
91.48 Mb, CFA 21q24.2-qtel:44.37–53.93 Mb, and
CFA 24q11.1-q24:3.06–39.45 Mb and a partial gain at
CFA 9q22.3:36.29–41.71 Mb. Data from oaCGH were
supported by FISH analysis on all three lots of MDCK
cells, the results of which are summarized in Fig. 7.
Discussion
The CKB1-3T7 cell line offers a unique tool for the
in vitro evaluation of spontaneous neoplastic activity.
The generation of cell banks from CKB1-3T7 at regular
intervals permits characterization of the progressive
Fig. 4 (continued)
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evolution of biological and genomic events involved in
the pathway from initiation to immortalization and the
acquisition of a tumorigenic phenotype.We propose that
this series of well-characterized reagents also fills a
critical niche in our ability to comprehend the funda-
mental requirements for expression of a tumorigenic
phenotype in vivo. The CKB1-3T7 cell line exhibited
several key biological properties that support its use in
this context, including a gradual decrease in doubling
time accompanied by an increase in growth rate
(Fig. 1a), loss of contact inhibition (SOM Fig. 1C),
and a gradual increase in tumorigenicity (Fig. 1b). In
addition, wound-healing assays revealed a progressive
increase in the cell motility of CKB1-3T7 cells over
continued passage (SOM Fig. 2). We have shown a
similar association between cell migration and tumor-
forming ability in the VERO line of AGMK cells
(Teferedegne et al. 2010, 2014).
Although key activities associated with the develop-
ment of a neoplastic phenotype were exhibited by
CKB1-3T7 cells, there was a deviation from the gener-
ally accepted order of events. For example, there was a
lack of association between loss of contact inhibition
and tumor formation in CKB1-3T7 cells. It is generally
considered that cells need an unrestricted capacity to
divide in order to form tumors in vivo. CKB1-3T7 cells,
however, expressed the capacity to form tumors in new-
born athymic nude mice at p51, and in both newborns
and adults at p81, passages when their growth remained
inhibited by cell-to-cell contact in culture. From p52 to
p82, population DT decreased by 26 % from 42.7 to
31.7 h. At p90, when loss of contact inhibition occurred,
the DT declined further only modestly to 28.1 h. We are
not aware of prior studies that assessed the effects of DT
and contact inhibition on the tumor-forming ability of
cells immortalized during spontaneous neoplastic devel-
opment in vitro. There are two possible explanations for
the apparent lack of correlation between the loss of
contact inhibition and the acquisition of a tumorigenic
phenotype. First, while the presence of a small number
of the 107 cells comprising the inoculum is likely suffi-
cient to form a tumor in vivo, loss of contact inhibition
in vitro requires that most of the cells have acquired this
property. Second, it is not known whether cells that are
contact inhibited in vitro are also contact inhibited
in vivo, where factors in the microenvironment might
allow cells to overcome such inhibition.
Perhaps the most dramatic property exhibited by
sequential passages of CKB1-3T7 cells was the progres-
sive reduction in tumor latency, falling from 28 weeks
(p51) to 2 weeks (p90) in newborn nude mice and from
53 weeks (p60) to 2 weeks (p90) in adult nude mice
Fig. 5 DNA copy number profiles of MDCK V1, MDCK V2,
and MDCK V3 cells obtained by oaCGH analysis. The horizontal
axis indicates the genomic location of arrayed probes and the
vertical axis indicates the log2 test:reference value at that locus
for each of the three MDCK lots. Color-matched horizontal bars
above and below each CGH profile delineate regions of DNA
copy number gain and loss, respectively. Each MDCK profile
shows an apparent copy number increase of CFA X, relative to
the male reference. Data fromCKB1-3T7 cells at p92 are included
to aid comparison with data from MDCK cells
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(Fig. 1b). From p62 to p92, the DT decreased from 30.4
to 28.1 h (Fig. 1a), which seems disproportionately
small compared with the marked reduction in tumor
latency, suggesting that these events may not be related
directly. Understanding the relationship between DT,
tumor incidence, tumor latency, and the loss of contact
inhibition requires, in part, knowledge of the genomic
alterations occurring in concert with these phenotypic
changes. A limited number of studies have attempted to
identify genomic alterations that correlate with the spon-
taneous emergence of immortalization and tumorigenic-
ity in vitro. Certain discrete CNAs have been shown to
be conserved between independent clones developed
from a common parental cell line, suggestive of a non-
random etiology [for example (Ray et al. 1986)], but no
comprehensive genome-wide studies exist. Despite
long-term propagation in culture, the majority of
CNAs evident in CKB1-3T7 cells (as late as p92), and
also in MDCK cells (beyond p55), were whole chromo-
some aneuploidies rather than focal imbalances of
individual genes or discrete subchromosomal regions
(Fig. 5). This suggests that the development of a tumor-
igenic phenotype may occur within a background of
limited genomic instability, at least in terms of DNA
copy number. Detailed characterization of structural,
mutational, transcriptional, and epigenetic alterations
in CKB1-3T7 cells will be required to reveal the relative
contribution of these factors in the acquisition of a
tumorigenic phenotype.
Among the small number of targeted genomic imbal-
ances detected in CKB1-3T7 cells was focal deletion of
a 1.04-Mb region at CFA 11q16:44.17–45.20 Mb,
which encodes the MTAP, CDKN2A/B, and DMRTA1
loci. Deletion of CFA 11q16:44.17–45.20 Mb was one
of the earliest detectable CNAs, evident first at p15 as a
hemizygous deletion in a proportion of the cell popula-
tion, and increasing dramatically in penetrance over the
next 30 passages before plateauing from p43 onwards as
a homozygous deletion (Fig. 3). The progressive loss of
this locus during sequential passage in vitro paralleled
a b
c d
Fig. 6 Multicolor FISH of
MDCK cells using sex
chromosome-specific SLPs. SLPs
were generated using clones from
the CHORI-82 canine BAC
library [CFA Xp21 (317O17,
gold) and Xp22.3/Yp11.3
(315K06, red)] and the RPCI-81
canine BAC library [CFAYq11.1
(079A18, pink) and Yp11.1
(183L18, green)]. aHybridization
of each SLP to clinically healthy
male dog control chromosomes.
The inset shows enlarged and
correctly oriented CFA X and
CFAY from this metaphase
chromosome spread with each
SLP signal identified by the
corresponding BAC clone
address. Clone 315K06
hybridized to both CFA X and Y,
consistent with its location within
the canine pseudoautosomal
region. The same SLP panel was
hybridized to b MDCK V1 cells,
c MDCK V2 cells, and d MDCK
V3 cells. Size bars represent 5 μm
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the progressive decline in the DT and an increase in
growth rate of CKB1-3T7 cells (Figs. 1a and 2). The
genomic boundaries of this deletion remained stable
from initial onset at p15 to apparent homozygous dele-
tion by p92, representing an interstitial deletion within
the midregion of CFA 11, with the remainder of the
chromosome remaining grossly intact. Each of the three
MDCK lots also exhibited homozygous deletion of
CDKN2A/B, spanning a markedly smaller interval of
60 kb at CFA 11q16:44.23–44.29 Mb that lay below
the limits of detection by BAC-based SLP analysis.
CDKN2A/B represents a cyclin-dependent kinase inhib-
itor that binds to cyclin-dependent kinases (CDK4,
CDK6) and halts the cell cycle in the G1 phase, thus
arresting cell proliferation. Focal deletions involving the
MTAP and CDKN2A/B loci on CFA 11q16 are among
the most highly recurrent somatic CNAs in a broad
range of naturally occurring canine cancers, including
appendicular osteosarcoma, histiocytic sarcoma, and
non-Hodgkin’s lymphoma (Angstadt et al. 2011;
Hedan et al. 2011; Thomas et al. 2011; Karlsson et al.
2013). This region also harbors germline risk factors for
both osteosarcoma and histiocytic sarcoma in dogs
(Shearin et al. 2012; Karlsson et al. 2013). This associ-
ation with both somatic and germline aberrations in
spontaneous canine cancer, together with the temporal
relationship between copy number loss and tumor-
forming capacity in both CKB1-3T7 cells and MDCK
cells, emphasizes the fundamental role of this locus as a
driver of neoplastic activity both in vivo and in vitro.
Interstitial deletion of human chromosome 9p21,
resulting in loss of CDKN2A/B, is also widely regarded
to be a critical event in the development of numerous
diverse human cancers (for example, Kohno and Yokota
2006; Schiffman et al. 2010; Sarhadi et al. 2013; LaPak
and Burd 2014; Su et al. 2014). Furthermore, we (un-
published observations) and others (Osada et al. 2014)
have recently identified the same aberration in both
novel and established cell lines of the African green
monkey. The conservation of this molecular event in
three species not only points to the significance of these
genes in cancer development but might also offer new
opportunities to elucidate mechanisms of double-strand
breakage and rejoining involved in tumorigenesis
through a comparative structural analysis of chromatin
architecture.
The onset of the focal deletion of CFA 11q16:44.17–
45.20 Mb at p15 in CKB1-3T7 cells was accompanied
by monosomies of CFA 27 and CFA 36. Aside from the
progressively increasing amplitude of the CFA 11q16
deletion, and progressive loss of CFA 27, the overall
genome-wide DNA copy number profiles of CKB1-3T7
cells remained stable during the interval between p15
and p32. By p43, several changes to the CNA profiles
became evident, which were verified by targeted FISH
analysis (Fig. 4). Interestingly, however, the single-copy
loss of CFA 27 was no longer evident from p43 on-
wards. This return to a balanced state was suggestive of
an in vitro form of uniparental disomy (UPD) through
replication of the one remaining copy of CFA 27. It is
tempting to consider that this Bmonosomy rescue^ event
may be causally related to the subsequent evolution of a
neoplastic phenotype in CKB1-3T7 cells during propa-
gation to p52 through the unmasking of cancer-
associated mutations via copy number neutral loss of
heterozygosity. The incidence of UPD and the relation-
ship between UPD and cancer remain enigmatic. This is
due in large part to the historical challenges associated
with its detection, particularly where only a single snap-
shot of genomic status in vivo is available for evalua-
tion. To our knowledge, there have been no descriptions
of this phenomenon in the dog. The series of sequential
passages of the CKB1-3T7 cell line thus offers an op-
portunity to monitor the onset and consequences of
UPD in an in vitro system.
CKB1-3T7 cells exhibited a second transient CNA in
the form of a targeted gain of 9.6 Mb at CFA 5q34-
q35:76.21–85.77Mb, whichmanifested as a duplication
on one copy of CFA 5 (Fig. 4a). This aberration was
evident in 9 % of cells at p62 and persisted in 13 % of
cells through p73 before returning to a balanced state by
p92 (Fig. 4a). The proximal boundary of this region lies
within the canine ortholog of the WWOX gene. WWOX
(WW domain containing oxidoreductase) spans one of
the two most active fragile sites in the human genome
(FRA16D, human chromosome 16q23) and is disrupted
frequently in several human cancers (Drusco et al.
2011). There was no evidence for CNA surrounding
the canine FHIT gene on CFA 20q14, which lies within
the other highly active fragile site in the human genome.
FISH analysis revealed that the frequency of the hemi-
zygous duplication at CFA 5q34-q35 fell to a level that
was undetectable by CGH analysis at p92. It is possible
that this was due to the emergence of an abnormal
subclone of CKB1-3T7 that was subsequently diluted
out over continued culture. Alternatively, this may rep-
resent a second example of apparent UPD, in which the
aberrant copy of CFA 5 present at p62 and p73 was lost
676 R. Omeir et al.
during culture to p92, perhaps due to some deleterious
effect, and the remaining, grossly normal CFA 5 dupli-
cated to result in a return to balanced status. As with the
transient loss of CFA 27, there is, however, no clear
explanation for this observation.
Gain of CFA 13, which was first detected in CKB1-
3T7 cells at p43, was also evident in MDCKV2 and V3
(Fig. 5). In common with deletion of CDKN2A/B, CFA
13 gain is among the most highly recurrent CNAs across
the spectrum of spontaneously established tumor cell
lines and naturally occurring canine cancers, including
appendicular osteosarcoma, histiocytic sarcoma, glio-
ma, non-Hodgkin’s lymphoma, mucosal melanoma,
and urothelial carcinoma (Thomas et al. 2009, 2011;
Angstadt et al. 2011; Hedan et al. 2011; Seiser et al.
2013; Poorman et al. 2015; Shapiro et al. 2015).
Interestingly, CFA 13 gain was also among the first
CNAs to evolve in a panel of induced pluripotent stem
(iPS) cells generated from normal adult canine fibro-
blasts, which developed low-level aneuploidy during
prolonged culture in conjunction with the ability to
produce solid tumors in mice (Koh et al. 2013). The
CFA 13 gain therefore appears to be an early event in the
genomic evolution of spontaneous tumorigenesis both
in vitro and in vivo. CFA 13 harbors several key cancer
genes, most notably the c-MYC and c-KIT proto-
oncogenes; however, CFA 13 gain manifests primarily
as a whole chromosome aneuploidy, in contrast to the
recurrent focal deletion of CFA 11q16 (Thomas et al.
2009, 2011; Angstadt et al. 2011; Hedan et al. 2011;
Seiser et al. 2013; Poorman et al. 2015; Shapiro et al.
2015). In combination, this suggests that CFA 13 gain
may be a secondary event that is more closely related to
the architecture of the canine karyotype rather than
being fundamental to the onset of a tumorigenic pheno-
type. The samemay apply to loss of CFA 16, which, like
CFA 13 gain, was first detected in CKB1-3T7 cells at
p43. In common with CFA 13 gain, loss of CFA 16 is
also common to several spontaneous canine cancers,
particularly soft tissue sarcomas, including appendicular
osteosarcoma, hemangiosarcoma, histiocytic sarcoma,
and non-Hodgkin’s lymphoma (Angstadt et al. 2011;
Hedan et al. 2011; Thomas et al. 2011, 2014; Karlsson
et al. 2013). This CNA was not, however, detected in
any of the MDCK variants. Conversely, the CKB1-3T7
cell line and all three MDCK variants accumulated gain
of CFA 14 (Fig. 5). This aberration became evident in
CKB1-3T7 cells only at p92, several passages after the
acquisition of a tumorigenic phenotype and once cells
had lost contact inhibition and tumor latency fell to 2–
3 weeks (SOM Fig. 1B, C). Gain of CFA 14 may
therefore represent a secondary event associated with
prolonged culture and increasingly dysregulated cell
proliferation. This may apply equally to those additional
CNAs (gain of CFA 1, CFA 9, and CFA 38 and loss of
CFA 18) that occurred in CKB1-3T7 cells only after
prolonged culture beyond p62 (Fig. 2).
Despite the extensive use of MDCK cells as a re-
search tool over the past five decades, to our knowledge,
this report represents the first genome-wide molecular
cytogenetic characterization of this cell line. Our find-
ings concur with prior reports (Cassio 2013) indicating
that the total chromosome number and morphology of
MDCK cells has remained close to that of the normal
dog karyotype (2n=78), with acrocentric autosomes and
submetacentric sex chromosomes (Breen et al. 1999a).
Our findings do, however, contradict prior reports sug-
gesting the presence of a Y chromosome and/or origin
from a male donor [for example, (Gaush et al. 1966;
Noma et al. 1998)]. These contrasting observations in
part reflect the challenge of accurate dog chromosome
identification using conventional banding analysis. It is,
however, becoming increasingly apparent that inconsis-
tencies between studies involving MDCK cells may
arise due to the use of different variants of this cell line.
Several derivatives of the original MDCK line are in use
today, with extensive heterogeneity evident in their cel-
lular morphology and biological behavior (Dukes et al.
2011; Omeir et al. 2011). Furthermore, MDCK cells
exhibit additional genomic and phenotypic Bdrift^ dur-
ing continued propagation (Dukes et al. 2011; Cassio
2013). Provenance is a particular concern when cell
lines are sourced from individual laboratories rather than
from centralized repositories, and resulting data fre-
quently are reported without detailed description of their
origin, culturing conditions, and number of population
doublings since initiation. The present study offers a
panel of widely accessible and biologically character-
ized reagents that can serve as a baseline reference for
standardization and integration of future studies utilizing
the CKB1-3T7 cell line.
The mechanistic association between genomic insta-
bility and cancer in humans has been explored in depth
(Thompson and Compton 2011), and it is increasingly
evident that seemingly limited defects can have substan-
tial consequences. For example, the renowned
Philadelphia chromosome rearrangement in chronic
myelogenous leukemia is sufficient to drive the disease
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(Chandra et al. 2011; Frankfurt and Licht 2013), and
there is evidence that artificial induction of a single
chromosome aberration may drive the onset of in vitro
neoplastic transformation in vertebrate cells (Gascoigne
and Cheeseman 2013). Our understanding of these dy-
namic processes remains incomplete, however, particu-
larly in the definition of cause versus effect and the
temporal basis of these events. We have shown previ-
ously that chromosome aberrations in naturally occur-
ring canine cancers parallel those of their human coun-
terparts (Breen and Modiano 2008; Thomas et al. 2009,
2011, 2014; Angstadt et al. 2011; Karlsson et al. 2013;
Poorman et al. 2015; Shapiro et al. 2015) and also
coincide with genomic rearrangements that arise during
speciation (Becker et al. 2011). The present study high-
lights a subset of chromosome aberrations that are also
common to spontaneous neoplastic development
in vitro and reveals their temporal relationships in con-
text with the evolution of biological behavior.
Continued assessment of genomic characteristics that
are shared between in vitro models and naturally occur-
ring disease across genetically distinct species should
aid in the elucidation of driving factors that are funda-
mentally involved in the onset of these phenotypes. The
CKB1-3T7 cell line offers a systematic tool for evalu-
ating safety concerns associated with vaccines devel-
oped in immortalized cells and for identification of
novel targets for effective modulation of tumorigenesis
in spontaneous cancers.
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